Effect of mirtazapine and paroxetine on residual symptoms of depressive disorders and their effect on P450 CYP 2D6 activity

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F01%3A00007662" target="_blank" >RIV/00216224:14110/01:00007662 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Effect of mirtazapine and paroxetine on residual symptoms of depressive disorders and their effect on P450 CYP 2D6 activity

Original language description

The issues related to preventing a relapse of depressive disorder are high on the list of priorities of psychiatry.The achievement of only a partial remission is a predictor of a higher incidence of relapses.30 patients displaying residual symptoms of depressive disorder were treated with paroxetine or mirtazapine in the conditions of a double-blind study involving monitoring CYP 2D6 activity.Both mirtazapine and paroxetine had a positive effect on residual symptoms of depressive disorder.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FL - Psychiatry, sexology

OECD FORD branch

—

Project

<a href="/en/project/NF6159" target="_blank" >NF6159: Phenotype dynamics in patient treated by paroxetine regarding the clinical correlates</a><br>

Continuities

Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year

2001

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Homeostasis

ISSN

0960-7560

e-ISSN

—

Volume of the periodical

41

Issue of the periodical within the volume

6

Country of publishing house

IT - ITALY

Number of pages

9

Pages from-to

242-249

UT code for WoS article

—

EID of the result in the Scopus database

—